GB0909441D0 - Novel indole derivatives - Google Patents
Novel indole derivativesInfo
- Publication number
- GB0909441D0 GB0909441D0 GBGB0909441.8A GB0909441A GB0909441D0 GB 0909441 D0 GB0909441 D0 GB 0909441D0 GB 0909441 A GB0909441 A GB 0909441A GB 0909441 D0 GB0909441 D0 GB 0909441D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- indole derivatives
- novel indole
- novel
- derivatives
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0909441.8A GB0909441D0 (en) | 2009-06-02 | 2009-06-02 | Novel indole derivatives |
PCT/GB2010/050896 WO2010139982A1 (en) | 2009-06-02 | 2010-05-28 | Indole derivatives for the stimulation of stem cell proliferation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0909441.8A GB0909441D0 (en) | 2009-06-02 | 2009-06-02 | Novel indole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0909441D0 true GB0909441D0 (en) | 2009-07-15 |
Family
ID=40902443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0909441.8A Ceased GB0909441D0 (en) | 2009-06-02 | 2009-06-02 | Novel indole derivatives |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0909441D0 (en) |
WO (1) | WO2010139982A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012154967A1 (en) * | 2011-05-12 | 2012-11-15 | Proteostasis Therapeutics, Inc. | Proteostasis regulators |
AU2014208964B2 (en) | 2013-01-23 | 2016-09-01 | Astrazeneca Ab | Chemical compounds |
WO2015073528A1 (en) | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
WO2016112088A1 (en) * | 2015-01-06 | 2016-07-14 | Spero Therapeutics, Inc. | Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors |
WO2020059841A1 (en) | 2018-09-21 | 2020-03-26 | 国立大学法人 長崎大学 | Therapeutic agent for prion diseases |
CN113603694B (en) * | 2021-07-16 | 2022-07-22 | 浙江工业大学 | 1, 2-diketone compound and preparation method and application thereof |
CN115317480B (en) * | 2022-09-01 | 2023-05-16 | 新乡医学院 | Pharmaceutical use of N- (3-methyl-5-isothiazolyl) -2-oxo-3- (2H) -benzoxazole acetamide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5192770A (en) * | 1990-12-07 | 1993-03-09 | Syntex (U.S.A.) Inc. | Serotonergic alpha-oxoacetamides |
DE19814838C2 (en) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylic acid derivatives with anti-tumor effects |
MX2007005434A (en) * | 2004-11-08 | 2007-07-10 | Baxter Int | Nanoparticulate compositions of tubulin inhibitor. |
EP1865949B1 (en) * | 2005-03-11 | 2012-11-14 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
ES2332822T3 (en) * | 2005-11-28 | 2010-02-12 | Choongwae Pharma Corporation | EXPASION WITHOUT SERUM OF CELLS IN CULTURE. |
GB0701426D0 (en) * | 2007-01-25 | 2007-03-07 | Univ Sheffield | Compounds and their use |
-
2009
- 2009-06-02 GB GBGB0909441.8A patent/GB0909441D0/en not_active Ceased
-
2010
- 2010-05-28 WO PCT/GB2010/050896 patent/WO2010139982A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010139982A1 (en) | 2010-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1173142A1 (en) | N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5- | |
HK1172893A1 (en) | 5-fluoropyrimidinone derivatives 5- | |
IL219087A0 (en) | Benzimidazole-imidazole derivatives | |
GB0905328D0 (en) | Indole derivatives | |
IL216007A0 (en) | Isoxazole-pyridine derivatives | |
HK1149762A1 (en) | Substituted indole derivatives | |
IL215109A0 (en) | Isoxazole-pyridazine derivatives | |
EP2406248A4 (en) | Novel isoindolin-1-one derivative | |
IL214941A0 (en) | Isoxazole-pyrazole derivatives | |
IL213927A0 (en) | Deoxyactagardine derivatives | |
HK1172894A1 (en) | N1-acyl-5-fluoropyrimidinone derivatives n1--5- | |
HK1169623A1 (en) | Pyrazinooxazepine derivatives | |
EP2460796A4 (en) | Indole derivative | |
GB0909441D0 (en) | Novel indole derivatives | |
EP2394990A4 (en) | Indoline derivatives | |
IL225393A0 (en) | Indole derivatives | |
GB0921967D0 (en) | Novel Aryloxyanilide Derivatives | |
EP2512482A4 (en) | 2-aldoximino-5-fluoropyrimidine derivatives | |
HK1173134A1 (en) | Substituted halophenoxybenzamide derivatives | |
IL213262A0 (en) | Tetrahydronaphthalen-2-ol derivatives | |
GB0912499D0 (en) | Indopyl-pyridone derivatives | |
EP2448921A4 (en) | Aryl indole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |